# A Trial of SHR-1819 in Healthy Subjects

> **NCT04561128** · PHASE1 · COMPLETED · sponsor: **Atridia Pty Ltd.** · enrollment: 42 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** SHR-1819
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04561128
- **Lead sponsor:** Atridia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-01
- **Primary completion:** 2022-03-07
- **Final completion:** 2022-03-07
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2022-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04561128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04561128, "A Trial of SHR-1819 in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04561128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*